Vicapsys Life Sciences, Inc. Proceeds from Convertible Debt
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2025-01-10
- 2024-09-30: Proceeds from Convertible Debt 9 month $75.00K.
- 2023-09-30: Proceeds from Convertible Debt 9 month $290.35K.
| Period end | Proceeds from Convertible Debt 9 month |
|---|---|
| 2024-09-30 | $75.00K 10-Q · filed 2025-01-10 |
| 2023-09-30 | $290.35K 10-Q · filed 2025-01-10 |